Sabry Nirmeen, Dawoud Dalia, Alansary Adel, Hounsome Natalia, Baines Darrin
Clinical Pharmacy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Health Economics, Modelling and Systems Analysis (HeMaSa), Centre for Technology Enabled Health Research, Coventry University, Coventry, UK.
J Eval Clin Pract. 2015 Dec;21(6):1081-8. doi: 10.1111/jep.12463. Epub 2015 Oct 22.
RATIONALE, AIMS AND OBJECTIVES: Timely switching from intravenous to oral therapy ensures optimized treatment and efficient use of health care resources. Intravenous (IV) paracetamol is widely used for post-operative pain management but not always switched to the oral form in a timely manner, leading to unnecessary increase in expenditure. This study aims to evaluate the impact of a multifaceted intervention to promote timely switching from the IV to oral form in the post-operative setting.
An evidence-based prescribing protocol was designed and implemented by the clinical pharmacy team in a single district general hospital in Egypt. The protocol specified the criteria for appropriate prescribing of IV paracetamol. Doctors were provided with information and educational sessions prior to implementation. A prospective, quasi-experimental study was undertaken to evaluate its impact on IV paracetamol utilization and costs. Data on monthly utilization and costs were recorded for 12 months before and after implementation (January 2012 to December 2013). Data were analysed using interrupted time series analysis.
Prior to implementation, in 2012, total spending on IV paracetamol was 674 154.00 Egyptian Pounds (L.E.) ($23,668.00). There was a non-significant (P > 0.05) downward trend in utilization (-32 ampoules per month) and costs [reduction of 632 L.E. ($222) per month]. Following implementation, immediate decrease in utilization and costs (P < 0.05) and a trend change over the follow-up period were observed. Average monthly reduction was 26% (95% CI: 24% to 28%, P < 0.001).
A multifaceted, protocol-based intervention to ensure timely switching from IV-to-oral paracetamol achieved significant reduction in utilization and cost of IV paracetamol in the first 5 months of its implementation.
原理、目的与目标:及时从静脉给药转换为口服给药可确保优化治疗并有效利用医疗资源。静脉注射对乙酰氨基酚广泛用于术后疼痛管理,但并非总能及时转换为口服剂型,导致费用不必要增加。本研究旨在评估多方面干预措施对促进术后及时从静脉注射剂型转换为口服剂型的影响。
埃及一家单区综合医院的临床药学团队设计并实施了一项循证处方方案。该方案规定了静脉注射对乙酰氨基酚的合理处方标准。在实施前为医生提供了信息和教育课程。进行了一项前瞻性、准实验研究,以评估其对静脉注射对乙酰氨基酚使用情况和成本的影响。记录了实施前后12个月(2012年1月至2013年12月)的每月使用情况和成本数据。使用中断时间序列分析对数据进行分析。
在实施前的2012年,静脉注射对乙酰氨基酚的总支出为674154.00埃及镑(L.E.)(23668.00美元)。使用量(每月减少32支安瓿)和成本(每月减少632埃及镑(222美元))呈非显著下降趋势(P>0.05)。实施后,观察到使用量和成本立即下降(P<0.05),且在随访期内出现趋势变化。平均每月减少26%(95%置信区间:24%至28%,P<0.001)。
一项基于方案的多方面干预措施,确保及时从静脉注射对乙酰氨基酚转换为口服剂型,在实施后的前5个月内,静脉注射对乙酰氨基酚的使用量和成本显著降低。